NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,036,000 | +2.3% | 60,589 | +0.1% | 0.45% | -5.8% |
| Q4 2018 | $1,990,000 | +23.7% | 60,549 | +83.7% | 0.48% | +55.0% |
| Q2 2018 | $1,609,000 | -88.8% | 32,960 | -75.6% | 0.31% | -88.4% |
| Q1 2018 | $14,378,000 | +263.7% | 135,312 | +104.4% | 2.67% | +226.0% |
| Q4 2017 | $3,953,000 | +25.0% | 66,200 | -49.8% | 0.82% | -6.9% |
| Q3 2017 | $3,162,000 | +29.7% | 131,757 | +5.7% | 0.88% | +22.4% |
| Q2 2017 | $2,437,000 | -40.8% | 124,632 | -28.9% | 0.72% | -30.0% |
| Q1 2017 | $4,115,000 | – | 175,315 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |